Proteomic biomarkers can be used to diagnose diseases, including cancer, cardiovascular disease, and neurological disorders.[7] For example, carcinoembryonic antigen (CEA) is a protein biomarker that is used to monitor the progression of types of cancer, including colon, lung, and breast cancer. This evidence concerns the gene CEACAM5 and nervous system disorder.